HGF are proud to be attending the CRISPR Based Medicine Congress in London.
The CRISPR Based Medicine Congress will be held in London on Wednesday 23rd October-Friday 25th October. This event will explore innovations in multi-omic research from NGS and single-cell sequencing through to spatial imaging, CRISPR technology and beyond.
Partner and Patent Attorney Douglas Drysdale will be speaking on the panel 'The IP Space for CRISPR & Gene Editing Technology'
Click the button below to find out more